BioLineRx (BLRX) Institutional Ownership $3.06 +0.20 (+6.99%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.04 -0.02 (-0.49%) As of 05/22/2026 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$136.96K Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter BioLineRx Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/17/2025 Citadel Advisors LLC10,020$38K0.0%-78.3%0.230% 2/12/2025Highbridge Capital Management LLC1,010,012$215K0.0%N/A50.501% 11/1/2024Atria Investments Inc133,974$72K0.0%+27.9%0.168% 8/22/2024PVG Asset Management Corp123,580$70K0.3%N/A0.155% 8/15/2024CVI Holdings LLC815,683$462K0.4%N/A1.020% 3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023Values First Advisors Inc.48,348$88K0.1%N/A0.079% 10/11/2023Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/4/2022Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, the following institutional investors and hedge funds held shares of BioLineRx shares: CVI Holdings LLC ($462K), Highbridge Capital Management LLC ($215K), Atria Investments Inc ($72K), and PVG Asset Management Corp ($70K), Citadel Advisors LLC ($38K).Learn more on BioLineRx's institutional investors. What percentage of BioLineRx's stock is owned by institutional investors? 1.56% of BioLineRx's stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx's stock? The following institutional investors have purchased BioLineRx's stock in the last 24 months: Highbridge Capital Management LLC ($1.01M), CVI Holdings LLC ($815.68K), PVG Asset Management Corp ($123.58K), and Atria Investments Inc ($29.19K). Which of BioLineRx's major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: Citadel Advisors LLC ($36.23K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 36,234 shares in the last 24 months. This volume of shares sold represents approximately $136.96K in transactions. Related Companies ESLA Institutional Ownership MGX Institutional Ownership OKUR Institutional Ownership ZYBT Institutional Ownership ELUT Institutional Ownership IXHL Institutional Ownership XLO Institutional Ownership INCR Institutional Ownership ATOS Institutional Ownership LITS Institutional Ownership This page (NASDAQ:BLRX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThis small stock could surge when SpaceX goes publicWhen SpaceX goes public, billions in capital won't just flow into one stock - it will flood the entire sector....NXT Wave Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredOne coin wired into Elon's visionSpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...Crypto 101 Media | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
